Delivery straight to the brain
NanoCarry offers a unique theranostic approach of a nanoparticle-based platform that can efficiently overcome the restrictive mechanism of the Blood-Brain-Barrier (BBB), and deliver bio-therapeutics into the brain. Our commitment to alleviate the suffering of patients with neurological disorders, remains the key driving force behind our Biotechnology Startup. Our team of professionals is here to inspire you with their unique ideas and abilities.
We’re a young and talented group of researchers, entrepreneurs and engineers offering an innovative solution that will provide a better future for those who suffer from neurological disorders. Our innovative targeted delivery solution for crossing the blood-brain-barrier (BBB) can be adapted to any need.
Our Innovative Technology
NanoCarry aims to alleviate the suffering of patients with neurological disorders, by combining known disease targets and compounds together with an established drug delivery technology for safe targeting. Our nanoparticle-based platform allows precise targeting of prominent molecular pathways, cells, and tissue types involved in the disease. NanoCarry's hybrid nanoparticles are based on an innovative, patent-protected drug delivery and imaging technique. This versatile nanoplatform technology can be applied to a pipeline of products, with the potential for a transformative impact on the treatment of a broad spectrum of neurological conditions, such as Alzheimer's, Parkinson's and ALS, as well as brain cancer and rare genetic diseases.
The NanoCarry Team
Prof. Rachela Popovtzer
Co-Founder & CSO
Professor and Vice-Dean, Faculty of Engineering, Bar Ilan University.
Expert in nanomedicine, and development of 'smart' nanoprobes for theranostic applications.
Oshra Betzer, PhD
Co-Founder & CEO
Bar Ilan post-doctoral fellow in Nano-Bioengineering; PhD in Bioengineering & Neuroscience.
Experience in managing positions in the high-tech industry.
Get in Touch
UnBox, Bar Ilan Universty, Ramat Gan